What's Happening?
Children's Mercy Hospital has earned the Platinum Level Center of Excellence designation from the Extracorporeal Life Support Organization (ELSO) for its ECMO program, the highest recognition awarded globally. This distinction acknowledges excellence
in patient care, education, quality improvement, and program development. The hospital's multidisciplinary team recently demonstrated its innovative approach in the case of Joshlynn, a premature infant born at 26 weeks with severe cystic bronchopulmonary dysplasia (BPD). Joshlynn's complex condition, including large air-filled cysts in her lungs affecting her heart, led the team to utilize ECMO (Extracorporeal Membrane Oxygenation) as a bridge to surgery. ECMO temporarily takes over lung function, allowing the organs to rest and heal. This enabled surgeons to safely remove the cysts, a procedure that would have been impossible given her critical state. Children's Mercy is also a founding member of the international BPD Collaborative, focusing on the unique needs of children with severe lung disease and their long-term outcomes.
Why It's Important?
The Platinum Level Center of Excellence designation for Children's Mercy's ECMO program is a significant achievement, underscoring the hospital's leadership in critical care for pediatric patients. This recognition not only validates the high standards of care provided but also enhances the hospital's reputation as a referral center for complex cases. For families across the U.S., this means access to one of the world's most advanced life support systems for children with severe respiratory and cardiac conditions. The innovative use of ECMO, as demonstrated in Joshlynn's case, highlights how specialized medical interventions can create pathways for otherwise impossible surgeries, offering hope for children with life-threatening conditions. This approach also contributes to the broader medical community by setting benchmarks for best practices in ECMO and BPD care, potentially influencing treatment protocols in other institutions. The hospital's involvement in the international BPD Collaborative further emphasizes its commitment to advancing research and improving outcomes for children with chronic lung diseases, impacting future generations of patients.
What's Next?
Children's Mercy Hospital will continue to leverage its Platinum Level ECMO program and BPD expertise to treat critically ill infants and children. The hospital's ongoing participation in the international BPD Collaborative suggests a continued commitment to research and development in chronic lung diseases, potentially leading to new treatment modalities and improved long-term outcomes for patients. The success stories, like Joshlynn's, will likely serve as case studies for medical education and inspire further innovation within the field. The hospital may also see an increase in referrals for complex pediatric cases requiring advanced life support. Furthermore, the recognition could attract top medical talent, strengthening the hospital's multidisciplinary teams. The focus on less sedation and continued development for infants on ECMO indicates a trend towards more patient-centered care, which may become a standard practice in other leading institutions.
Beyond the Headlines
The story of Joshlynn and Children's Mercy's ECMO program delves into the ethical and emotional complexities of pediatric critical care. The decision to use highly specialized and invasive life support, like ECMO, for extremely premature infants with severe conditions raises questions about quality of life, long-term prognosis, and the immense emotional and financial burden on families. However, the hospital's philosophy of 'trying just about anything' when there's a chance of success highlights a profound commitment to preserving life and exploring every possible avenue for recovery. The emphasis on patient development and engagement even while on ECMO, through collaboration with Child Life specialists and therapists, reflects a holistic approach to care that goes beyond mere survival. This case also underscores the critical role of specialized medical transport teams in ensuring timely access to advanced care for infants in remote areas, highlighting disparities in healthcare access. The long-term support provided by the Infant Tracheostomy and Home Ventilator Program further illustrates the evolving landscape of chronic care, where medical interventions extend far beyond hospital walls, integrating complex medical needs into daily family life.
